EDITOR'S NOTE: Big4Bio newsletters will not
be published on Monday, Jan 20th; they will
resume distribution on Tuesday, Jan 21st.
|
|
* - may be subscription-only |
|
- Boston Scientific: Late-Breaking Data Presented at
AF Symposium 2025 Highlight Key Boston Scientific
Therapies for Management of Patients With Atrial
Fibrillation More
- Foundation Medicine: U.S. Food and Drug
Administration Approves FoundationOneCDx as a
Companion Diagnostic for OJEMDA (tovorafenib) to
Treat the Most Common Form of Childhood Brain Tumor
in Pediatric Patients More
- iSpecimen: Secures Suppliers for COVID-style hMPV
Outbreak More
- Zai Lab: Acceptance of New Drug Application for
KarXT for the Treatment of Schizophrenia More
|
|
|
Section
Sponsor:
|
|
|
|
|
- Ocular Therapeutix: Inducement Grant Under Nasdaq
Listing Rule 5635(c)(4) More
- Phio Pharmaceuticals: $1.83 Million Registered
Direct Offering Priced At-the-Market Under Nasdaq
Rules More
|
|
|
Section
Sponsor:
|
|
|
|
|
- Biggest Boston Biotech News Coming Out of JPM
2025 More*
- Broad: Study Finds Surprising Way That Genetic
Mutation Causes Huntington’s Disease, Transforming
Understanding of the Disorder More
More More*
- Join Big4Bio CBO Dave Whelan in Munich for DxPx;
Save With a Special Discount Code! More
- More on Lyndra Therapeutics Signing Manufacturing
Agreement With Thermo for Long-Acting Oral Therapies
More
- Subscribe to LifeSci Startup for Updates on
US Startups More
|
|
|
Section
Sponsor:
|
|
|
|
SECTION SPONSOR: |
|
|
|
- Big4Bio:Boston Life Science Company
Directory More
|
NOTE:
EVENTS AND JOBS ARE FROM ALL BIG4BIO REGIONS
|
|
|
|
|
|
Section
Sponsor:
|
|
|
|
|
- OPPORTUNITY: Senior Director, Integrated Marketing
& Communications - Remote More
- OPPORTUNITY: Clinical Development Leader - New York,
NY More
- OPPORTUNITY: Sales Executive - Hybrid More
- OPPORTUNITY: Senior Director of Business Development
- Remote More
- OPPORTUNITY: Vice President of North America Medical
Affairs - MA More
- OPPORTUNITY: Vice President of Sales &
Marketing, North America - Remote More
|
|
|
Section
Sponsor:
|
|
|
|
|